Brief: Epigenomics: Gregory Hamilton appointed as CEO
30/06/2016 20:17
July 1 (Reuters) - Epigenomics AG ECXn.DE :
* Said on Thursday Supervisory Board of Epigenomics appointed Gregory Hamilton as Chief
Executive Officer (CEO) with effect from July 1, 2016
* Thomas Taapken, who has served in the dual role of CEO and CFO since 2012, will leave the
company with effect of June 30, 2016
* Vacant CFO position will be filled shortly
Source text for Eikon: ID:nEQbHmcWva
Further company coverage: ECXn.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns